antitrust News
Most Popular antitrust Story
FTC sues over 'pay-for-delay' generics deal
The Federal Trade Commission is targeting pay-for-delay deals between branded drugmakers and generics firms. In an attempt to block one such deal--in which Solvay Pharmaceuticals paid three generics Read more...
Latest Headlines
- December 2, 2011
- November 11, 2011
- October 24, 2011
- October 21, 2011
- July 6, 2011
- April 29, 2011
- January 21, 2011
- January 18, 2011
- December 3, 2010
- July 6, 2010
- July 1, 2010
- May 20, 2010
- May 4, 2010
- March 30, 2010
- January 15, 2010
- January 12, 2010
- December 9, 2009
- October 7, 2009
- October 6, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
